Atlas Trials

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

Clinical trial NCT03476798 · COMPLETED

Trial details

NCT number
NCT03476798
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical CancerEndometrial Cancer
Start date
2018-06-29
Primary completion
2020-05-12
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.